KATHLEEN ELLIOTT: Open Payments
NPI 1275756462 · NEW BEDFORD, MA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$785 in 28 payments from 9 companies in 2025. Trend: 2023 $787 · 2024 $542 · 2025 $785
Food & beverage: $785
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 9 | $220 |
| ABBVIE INC. | 4 | $180 |
| Exact Sciences Corporation | 4 | $114 |
| Indivior Inc. | 3 | $89 |
| Lilly USA, LLC | 3 | $72 |
| Novo Nordisk Inc | 2 | $44 |
| Phathom Pharmaceuticals, Inc. | 1 | $24 |
| Abbott Laboratories | 1 | $22 |
| Viatris Specialty LLC | 1 | $21 |
Products named: FARXIGA, The Cologuard Plus Collection Kit, RINVOQ, SUBLOCADE, VRAYLAR, MOUNJARO, AIRSUPRA, VOQUEZNA.
Industry payments across MA — which companies pay providers there.
